Rashmi Pharma Private Limited, a active private limited company, was established on 19 April 1999 in Andhra Pradesh, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG1999PTC031538. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.04 Cr.
It upholds a compliant status. Employing 46 professional, Its leadership includes Gundrati Naga Bharath (Director), Gundrathi Sai Rashmi (Director), Gundrathi Prasuna (Whole-Time Director). Past directors included Gundrati Naga Bharath, Gundrathi Sai Rashmi, Gundrathi Prasuna. It holds ₹21.52 Cr open charges and ₹5.78 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.104/1, Phase-2,Ida Cherlapally,Ghatkesar, Rangareddy Dist, Andhra Pradesh, Telangana, 500051.
U24239TG1999PTC031538
031538
19 April 1999
₹2.50 Cr
₹2.04 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Rashmi Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gundrati Naga Bharath | Director | 08 Aug 2024 | Current |
| Gundrathi Sai Rashmi | Director | 06 May 2024 | Current |
| Gundrathi Prasuna | Whole-Time Director | 05 Aug 2019 | Current |
| Gundrati Jagannath | Managing Director | 19 Apr 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 01 Oct 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rashmi Pharma Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 31.59% decrease. The company also saw a substantial improvement in profitability, with a 110.22% increase in profit. The company's net worth moved up by a moderate rise of 3.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Rashmi Pharma had a public holding of 6.62%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹215,150,000.00
₹57,750,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2025 | State Bank Of India | ₹2.00 Cr | Open |
| 19 Aug 2023 | Hdfc Bank Limited | ₹2.45 M | Open |
| 18 Mar 2016 | State Bank Of India | ₹19.27 Cr | Open |
| 21 Jan 2015 | Kotak Mahindra Bank Limited | ₹1.50 Cr | Satisfied |
| 11 Dec 2012 | Hdfc Bank Limited | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Rashmi Pharma has a workforce of 46 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rashmi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rashmi Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with State Bank Of India amounted to Rs. 2.00 Cr with Charge ID 101147838 was registered on 08 Aug 2025. was completed.
Progress on A charge with State Bank Of India of Rs. 19.27 Cr registered on 18 Mar 2016 with Charge ID 100025982 was modified on 18 Dec 2024. was documented.
Progress on Rashmi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Gundrati Naga Bharath was appointed as a Director was appointed as a Director on 08 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The activity Gundrathi Sai Rashmi was appointed as a Director was appointed as a Director on 06 May 2024 & has been associated with this company since 1 year 7 months . was completed.
The activity Rashmi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The CIN of Rashmi Pharma Private Limited is U24239TG1999PTC031538.
Rashmi Pharma Private Limited is headquartered at Plot No.104/1, Phase-2,Ida Cherlapally,Ghatkesar, Rangareddy Dist, Andhra Pradesh, Telangana, 500051.
Rashmi Pharma Private Limited was incorporated on 19 April 1999.
The current directors of Rashmi Pharma Private Limited are
The primary industry of Rashmi Pharma Private Limited is Manufacturing.
Rashmi Pharma Private Limited is unlisted.
The authorized capital of Rashmi Pharma Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.04 Cr.
The compliance status of Rashmi Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX